NCT07561346
- Conditions
- HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories
- Locations
-
- Hellenic Cooperative Oncology Group (HeCOG) Athens, Greece
Clinical trial condition
HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories
Explore clinical trials studying HER2-zero, HER2-low and HER2-positive Tumors Distribution Across HR Expression Categories. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies